AKT1 and breast cancer: PTENP1 lncRNA activates the phosphatidylinositol-3 kinase (PI3K)/AKT pathway via the miR-20a/PTEN axis, leading to the proliferation, invasion, and drug resistance of BC cells, thus inhibiting apoptosis.